Intelence Linked To Stevens-Johnson’s Syndrome And Toxic Epidermal Necrolysis

On August 27, 2009, Intelence (Etravirine) the HIV medication made by Johnson & Johnson has been publicly acknowledged by Johnson & Johnson to have a relationship with severe skin conditions and reactions including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN’s). These are horrible and horrific skin conditions of burning and scarring throughout the body.

For a drug to cause SJS or TENS means the drug could cause a systemic hypersensitivity reaction, oftentimes accompanied by liver failure. Intelence obtained FDA approval in 2008. Its approval is for the treatment of HIV victims who become resistant to other HIV medications. Intelence is a Non-Nucleoside Reverse Transcriptase Inhibitor.

The warning label on Intelence has now been strengthened concerning severe skin reactions. The new label states Intelence should be immediately discontinued if symptoms of severe skin or skin hypersensitivity develop.

If you or a loved one has developed Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TENS) after use of Intelence, please immediately contact the national Stevens-Johnson Syndrome law firm of Nadrich & Cohen. We have been litigating and have successfully settled Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis cases nationwide.

There is no charge for our services until and unless we first obtain a recovery. We are contingency lawyers who charge a fair fee for our services. There is no cost to you unless we first obtain a recovery.  Since there are time deadlines please contact us as soon as possible. Otherwise, your rights may be lost.